Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development
Recent News
First Made-in-Singapore Antibody-Drug Conjugate EBC-129 progresses to Phase 1B Dose Expansion
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
XtalPi and EDDC sign MoU, minting new collaboration to empower biomedical innovation with robotics and Large Language Models (LLM)
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development
First Made-in-Singapore Antibody-Drug Conjugate EBC-129 progresses to Phase 1B Dose Expansion
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
XtalPi and EDDC sign MoU, minting new collaboration to empower biomedical innovation with robotics and Large Language Models (LLM)
EARO Review (2020 – 2022) – A Review of EARO’s first 3 years
BioCurate and EDDC Signs MoU To Announce Strategic Alliance
First Patient Dosed in Phase 1 trial of Antibody-Drug Conjugate EBC-129 in Patients with Solid Tumours
Cancer Research Horizons and EDDC announce 5-year alliance
First Made-in-Singapore Antibody-Drug Conjugate (ADC) Approved to Enter Clinical Trials
Your Own Prior Art: How to Avoid Shooting Yourself in the Foot!
EDDC Annual Drug Discovery Symposium 2024
Integrated IP Strategy for Platform Technologies and their Products
Exploring the Drug Discovery and Development Landscape with Boehringer Ingelheim
EDDC Satellite Seminar – Preclinical in vivo Studies for Drug Discovery and Development
EDDC Drug Discovery and Development Symposium: Navigating the Drug Discovery Journey
EDDC Satellite Seminar Series: Computer-Aided Drug Discovery Accelerates Novel Hit Discovery from an Extraordinary Chemical Space